The influence of catecholamines and related substances on human myocardial (Na +, K + )-ATPase.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D002395:Catecholamines / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D008333:Mandelic Acids / Q000494:pharmacology; D008861:Microsomes / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D009647:Normetanephrine / Q000494:pharmacology; D009994:Osmolar Concentration; D010649:Phenylalanine / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D014439:Tyramine / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology; D014642:Vanilmandelic Acid / Q000494:pharmacology
D002395:Catecholamines; D008333:Mandelic Acids; D009647:Normetanephrine; D014443:Tyrosine; D010649:Phenylalanine; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine